gdc

Lung Cancer

Biomarker Testing in Non–Small-Cell Lung Cancer: A Guide for Patients
BiomarkersLung Cancer

Non–small-cell lung cancer, or NSCLC, is the most common form of lung cancer, accounting for about 80% to 85% of all lung cancer cases in the United States.

Biomarkers in Lung Cancer: What Are They and Why Do They Matter?
BiomarkersGenetics & CancerLung Cancer
Patients with advanced lung cancer should be tested for the 5 most common biomarkers so they may receive the best treatment options for their disease.
Treatment of Non–Small-Cell Lung Cancer: A Guide for Patients
Lung Cancer
In the second article of this 4-part series, the authors present an overview of the current treatment landscape for NSCLC, including a description of the most often used treatments and common questions that patients can ask their providers.
Updated Joint Statement on Coronavirus (COVID-19) from Lung Cancer Groups
COVID-19Lung CancerWeb Exclusives
LUNGevity and 4 other lung cancer organizations have provided information on the new coronavirus for people with lung cancer and other patients with cancer. This update also provides reliable sources of information for patients.
COVID-19 FAQs for People with Lung Cancer
COVID-19Lung CancerWeb Exclusives
LUNGevity answers some frequently asked questions about patients with lung cancer and survivors and the coronavirus illness.
COVID-19 Conversation: Introduction
COVID-19Lung Cancer
In this series of videos from LUNGevity, oncologist Zosia Piotrowska, MD, MHS, Massachusetts General Hospital, Boston, addresses many of the questions and concerns raised in regard to coronavirus COVID-19 and patients with lung cancer.
COVID-19 Conversation: Part 1: About Coronavirus – COVID-19
COVID-19Lung Cancer
Oncologist Dr. Zosia Piotrowska addresses some specific questions about the impact of COVID-19. She discusses dealing with anxiety, symptoms, who is most at risk for the illness, how it is spread, how to avoid getting the illness, and the available treatments.
COVID-19 Conversation: Part 2: COVID-19 and Lung Cancer
COVID-19Lung Cancer
Dr. Zosia Piotrowska explains why COVID-19 is of special concern for patients with lung cancer and their caregivers. She addresses the question of treatment-related compromised immunity and the illness.
COVID-19 Conversation: Part 3: Practical Advice
COVID-19Lung Cancer
Some of the most frequently asked questions about COVID-19 include travel, social distancing, and other day-to-day matters for patients with lung cancer. Oncologist Dr. Zosia Piotrowska provides some answers.
Staging of Non–Small-Cell Lung Cancer: A Guide for Patients
Lung Cancer
Knowing the stage of lung cancer helps oncologists to plan the best treatment plan for each patient. This second article in the series explains how the most common type of lung cancer is staged.
Page 1 of 7
Results 1 - 10 of 66

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country